tiprankstipranks
Trending News
More News >
Recursion Pharmaceuticals (RXRX)
NASDAQ:RXRX
US Market

Recursion Pharmaceuticals (RXRX) Cash flow

Compare
4,417 Followers

Recursion Pharmaceuticals Cash Flow

RXRX's free cash flow for Q4 2025 was $-47.32M. For the 2025 fiscal year, RXRX's free cash flow was decreased by $-5.41M and operating cash flow was $-46.07M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -371.81M$ -359.17M$ -287.78M$ -83.52M$ -158.61M
Investing Cash Flow
$ -16.87M$ 260.06M$ -10.23M$ 193.25M$ -271.74M
Financing Cash Flow
$ 521.53M$ 304.12M$ 140.13M$ 154.34M$ 458.54M
End Cash Position
$ 753.92M$ 603.02M$ 401.43M$ 559.11M$ 295.35M
Free Cash Flow
$ -378.28M$ -372.87M$ -300.33M$ -120.88M$ -198.41M
Currency in USD

Recursion Pharmaceuticals Cash Flow